Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients.

被引：0
|
作者：
Porakishvili, N
Slovick, A
Jewell, AP
Youinou, PY
Nathwani, A
Yong, K
Stevenson, F
Clark, EA
Lydyard, PM
机构：
[1] Univ Westminster, Sch Biosci, London, England
[2] Royal Free & UCL Med Sch, London, England
[3] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England
[4] Brest Univ, Brest, France
[5] Univ Southampton, Tenovus Res Labs, Southampton SO9 5NH, Hants, England
[6] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1571
引用
收藏
页码：432A / 432A
页数：1
相关论文
共 50 条
  • [1] Is effective in the treatment of rTMS non-responder MDD patients.
    Dannon, PN
    Grunhaus, L
    JOURNAL OF ECT, 2001, 17 (01) : 81 - 81
  • [2] Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study
    Suliman, Reem
    Santos, Vanessa
    Al Qaisi, Ibrahim
    Aldaher, Batool
    Al Fardan, Ahmed
    Al Barrawy, Hajir
    Bader, Yazan
    Supena, Jonna Lyn
    Alejandro, Kathrina
    Alsaadi, Taoufik
    NEUROLOGY INTERNATIONAL, 2024, 16 (01): : 274 - 288
  • [3] Effectiveness of switching CGRP monoclonal antibodies in non-responder patients in the UAE: a retrospective study
    Suliman, R.
    Santos, V.
    Al Qaissi, I.
    Aldaher, B.
    Al Fardan, A.
    Al Barrawi, H.
    Bader, Y.
    Supena, J. L.
    Alejandro, K.
    Alsaadi, T.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] Determination of cytokine profile by single cell cytokine (SCC) analysis of IgE responder and non-responder schistosomiasis patients.
    Gollob, KJ
    Dutra, WO
    Fonseca, L
    Roberts, M
    Webster, M
    Fraga, L
    Silveira, AS
    Yssel, H
    Colley, DG
    Dunne, D
    CorreaOliveira, R
    FASEB JOURNAL, 1996, 10 (06): : 332 - 332
  • [5] Short term in vivo activity of Rituximab anti CD20 monoclonal antibody in B-CLL patients.
    Berchem, GJ
    Heintz, D
    Bosseler, M
    Duhem, C
    Ries, F
    Dicato, MA
    BLOOD, 1999, 94 (10) : 307B - 307B
  • [6] B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Unresponsive to CD180 Ligation Fail to Respond to Anti-IgM Stimulation as Well
    Porakishvili, Nino
    Lydyard, Peter
    Bremser, Anna
    Vispute, Ketki
    Memon, Azka
    Kulikova, Nina
    Clarke, Edward
    Rai, Kanti R.
    Nathwani, Amit
    Damle, Rajendra N.
    Chiorazzi, Nicholas
    BLOOD, 2010, 116 (21) : 1475 - 1475
  • [7] Hepatitis C viral dynamics with triple vs double therapy in non-responder patients.
    Jaeckel, E
    Koerbel, J
    Kunka, A
    Schueler, A
    Heringlake, S
    Wedemeyer, H
    Trautwein, C
    Magerstedt, P
    Zankel, M
    Brinkmann, S
    HEPATOLOGY, 1999, 30 (04) : 264A - 264A
  • [8] Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one
    Fresan-Restituto, Daniel
    Lacalle-Fabo, Esther
    Martin-Bujanda, Maria
    Teresa Sarobe-Carricas, M.
    REVISTA DE NEUROLOGIA, 2023, 76 (06) : 213 - 216
  • [9] Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
    Iannone, Luigi Francesco
    Burgalassi, Andrea
    Vigani, Giulia
    Tabasso, Giorgio
    De Cesaris, Francesco
    Chiarugi, Alberto
    Geppetti, Pierangelo
    CEPHALALGIA, 2023, 43 (04) : 1 - 11
  • [10] Differential expression of CD180 and sIgM by B chronic lymphocytic leukaemia cells (B-CLL) using mutated and unmutated IgVh genes.
    Porakishvili, N
    Kulikova, N
    Manoussaka, M
    Jewell, AP
    Youinou, PY
    Nedelec, S
    Yong, K
    Nathwani, A
    Heelan, B
    Hamblin, T
    Wallace, P
    Ely, P
    Clarke, E
    Lydyard, PM
    BLOOD, 2004, 104 (11) : 768A - 768A
12345